Thursday, October 31, 2019

Cadila Healthcare gets EIR from USFDA for Baddi facility

Cadila Healthcare gets EIR from USFDA for Baddi facility "The company#39;s formulations manufacturing facility located at Baddi, India, has received an EIR. The United States Food and Drug Administration (USFDA) had conducted an inspection at the facility from July 15 to 19, 2019," Cadila Healthcare said in a filing to BSE.

from Moneycontrol Business News https://ift.tt/2N1stW1
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Titagarh, Jupiter Wagons shares rally up to 10% amid reports of Rs 40,000 crore order from Indian Railways

Railway stocks surged up to 10% on Monday. Indian Railways is preparing a large tender for one lakh freight wagons. This procurement is expe...